We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Topic
- Advertising (236)
- COVID-19 (55)
- Compliance and enforcement (48)
- Vaping hub (33)
- Import and export (21)
- Medicinal cannabis hub (19)
- Safety monitoring and information (13)
- Scheduling (national classification system) (13)
- Manufacturing (11)
- Weight loss products (8)
- Legislation (7)
- Labelling and packaging (4)
- Shortages and supply disruptions (4)
- Cosmetics (3)
- Prescription opioids hub (2)
- Unique Device Identification (UDI) hub (2)
- Committees and advisory bodies (1)
- Fees and payments (1)
- Sunscreens (1)
Search
530 result(s) found, displaying 451 to 475
-
Media releasesThe Federal Court has imposed substantial penalties on Peptide Clinics Australia
-
Media releasesRisks associated with cosmetic injections can be related to both the product and the experience of the person performing the procedure
-
Media releasesThe TGA has clarified that state and territory governments will continue to regulate fluoridated drinking water in Australia
-
Media releasesThe TGA is urging Australians to return unused prescription pain relief medicines to their local pharmacy
-
Media releasesThe 2019 TGA stakeholder survey is open. Have your say before 5 July
-
Media releasesWe're encouraging all Australians to return their unused opioids to their local pharmacy
-
Media releasesInternational work-sharing initiative approves Niraparib (Zejula®)
-
Media releasesReasons for releasing guidance and how it was developed
-
Media releasesOn Thursday 30 May 2019, the Therapeutic Goods Administration (TGA) executed four search warrants connected to a business operating in the Sutherland Shire, Sydney
-
Media releasesThe TGA has seized black salve products after executing a search warrant at a business premises on the Gold Coast
-
Media releasesCourt action continues against Peptide Clinics Australia for alleged advertising breaches
-
Media releasesTGA data analysis
-
Media releasesSecond candidate in international work-share initiative
-
Media releasesInvitation to comment on discussion paper now published
-
Update to the advertising complaints and investigation information database improves search features
Media releasesThis update implements feedback from stakeholders to make the database more user-friendly -
Media releasesThe TGA is alerting consumers to the potential risks of purchasing electronic cigarette liquid
-
Media releasesDealing countefeit and unapproved medicines is a serious offence as shown in recent TGA prosecution outcome in South Australia
-
Media releasesThis legal action follows an investigation by the Therapeutic Goods Administration
-
Media releasesThere will not be a decision announced on scheduling of alkyl nitrites on 29 November 2018. Further public consultation will be undertaken.
-
Media releasesJoint media release between Australian Border Force and Therapeutic Goods Administration
-
Media releasesThe TGA has launched a web hub to help consumers and health professionals find information on transvaginal (urogynaecological) surgical mesh.
-
Media releasesToday we celebrate the official launch of the TGA Facebook page
-
Media releasesOur annual survey measures satisfaction with a range of services and activities including our role and performance
-
Media releasesApalutamide (Erlyand) is the first medicine approved via ACSS Consortium’s NCE working group
-
Media releasesConsumers can now report dodgy ads for medicines and medical devices through a single online form